These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy. Kazandjian D; Suzman DL; Blumenthal G; Mushti S; He K; Libeg M; Keegan P; Pazdur R Oncologist; 2016 May; 21(5):634-42. PubMed ID: 26984449 [TBL] [Abstract][Full Text] [Related]
3. FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer. Higuchi M; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Hasegawa T; Suzuki H World J Surg Oncol; 2016 Sep; 14(1):238. PubMed ID: 27595749 [TBL] [Abstract][Full Text] [Related]
5. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report. Li H; Ma W; Yoneda KY; Moore EH; Zhang Y; Pu LL; Frampton GM; Molmen M; Stephens PJ; Li T J Hematol Oncol; 2017 Feb; 10(1):64. PubMed ID: 28245875 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Bagley SJ; Kothari S; Aggarwal C; Bauml JM; Alley EW; Evans TL; Kosteva JA; Ciunci CA; Gabriel PE; Thompson JC; Stonehouse-Lee S; Sherry VE; Gilbert E; Eaby-Sandy B; Mutale F; DiLullo G; Cohen RB; Vachani A; Langer CJ Lung Cancer; 2017 Apr; 106():1-7. PubMed ID: 28285682 [TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer. Tanvetyanon T; Creelan BC; Antonia SJ Expert Rev Anticancer Ther; 2016 Sep; 16(9):903-10. PubMed ID: 27488231 [TBL] [Abstract][Full Text] [Related]
14. Nivolumab and pembrolizumab: Monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable. Prasad V; Kaestner V Semin Oncol; 2017 Apr; 44(2):132-135. PubMed ID: 28923211 [TBL] [Abstract][Full Text] [Related]
15. Nivolumab for the treatment of Japanese patients with advanced metastatic non-small cell lung cancer: a review of clinical trial evidence for efficacy and safety. Hida T Ther Adv Respir Dis; 2018; 12():1753466618801167. PubMed ID: 30249170 [TBL] [Abstract][Full Text] [Related]
16. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Rizvi NA; Mazières J; Planchard D; Stinchcombe TE; Dy GK; Antonia SJ; Horn L; Lena H; Minenza E; Mennecier B; Otterson GA; Campos LT; Gandara DR; Levy BP; Nair SG; Zalcman G; Wolf J; Souquet PJ; Baldini E; Cappuzzo F; Chouaid C; Dowlati A; Sanborn R; Lopez-Chavez A; Grohe C; Huber RM; Harbison CT; Baudelet C; Lestini BJ; Ramalingam SS Lancet Oncol; 2015 Mar; 16(3):257-65. PubMed ID: 25704439 [TBL] [Abstract][Full Text] [Related]
17. Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study. Teraoka S; Fujimoto D; Morimoto T; Kawachi H; Ito M; Sato Y; Nagata K; Nakagawa A; Otsuka K; Uehara K; Imai Y; Ishida K; Fukuoka J; Tomii K J Thorac Oncol; 2017 Dec; 12(12):1798-1805. PubMed ID: 28939128 [TBL] [Abstract][Full Text] [Related]
18. Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature. Ruiz-Bañobre J; Pérez-Pampín E; García-González J; Gómez-Caamaño A; Barón-Duarte FJ; López-López R; Vázquez-Rivera F Lung Cancer; 2017 Jun; 108():217-221. PubMed ID: 28625638 [TBL] [Abstract][Full Text] [Related]
19. Immune checkpoint inhibitors for nonsmall cell lung cancer treatment. Chen YM J Chin Med Assoc; 2017 Jan; 80(1):7-14. PubMed ID: 27693088 [TBL] [Abstract][Full Text] [Related]
20. Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence. Lim JS; Soo RA Ther Adv Respir Dis; 2016 Oct; 10(5):444-54. PubMed ID: 27480166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]